Literature DB >> 29138772

Mesoporous silica nanoparticles incorporating squaraine-based photosensitizers: a combined experimental and computational approach.

Ivana Miletto1, Alberto Fraccarollo, Nadia Barbero, Claudia Barolo, Maurizio Cossi, Leonardo Marchese, Enrica Gianotti.   

Abstract

Squaraine dyes, that exhibit intense absorption in the red/near infrared region, have been successfully introduced into mesoporous silica nanoparticles (MSNs) to obtain a nanoplatform for photodynamic therapy. Three brominated squaraine dyes which exhibited good PS performance in solution but a different behaviour in vitro due to cell permeability issues were used as photosensitizers. The effects of the adsorption within the pores of MSNs on the overall UV-Vis-NIR absorption and emission properties as well as on the PS performance was evaluated via a combined experimental and computational physico-chemical approach, which allowed us to correlate the unusual optical properties of two out of three systems with the dimerization of squaraines on the silica surface, with detrimental effects on the PS performance. Conversely, the nanoplatform where the squaraine molecules are adsorbed as monomers on the silica surface exhibited the best activity in singlet oxygen generation.

Entities:  

Year:  2018        PMID: 29138772     DOI: 10.1039/c7dt03735j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Red Upconverter Nanocrystals Functionalized with Verteporfin for Photodynamic Therapy Triggered by Upconversion.

Authors:  Ivana Miletto; Chiara Gionco; Maria Cristina Paganini; Erik Cerrato; Leonardo Marchese; Enrica Gianotti
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 2.  Polymethine dyes for PDT: recent advances and perspectives to drive future applications.

Authors:  Degnet Melese Dereje; Carlotta Pontremoli; Maria Jesus Moran Plata; Sonja Visentin; Nadia Barbero
Journal:  Photochem Photobiol Sci       Date:  2022-02-01       Impact factor: 3.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.